Aligos Therapeutics (ALGS) Other Non-Current Assets (2019 - 2026)
Aligos Therapeutics' Other Assets came in at $268,000 for Q3 2026, down 62.4% from $713,000 a year earlier and down 64.7% from the prior quarter.
Analysis
Aligos Therapeutics (ALGS) Other Non-Current Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Aligos Therapeutics' Other Assets was $715,000, up 14.0% from FY2024.
- Other Assets carries a five-year compound annual growth rate of -5.3% (FY2020 to FY2025).
- Going back by year, Other Assets was $627,000 in FY2024 (-9.8%), $695,000 in FY2023 (-7.2%), $749,000 in FY2022 (-27.3%) and $1.03 million in FY2021 (+9.9%).
- The Q3 2026 figure represents the lowest quarterly Other Assets since Q2 2023.
- Year-over-year, Other Assets increased in four of the last eight quarters, with an average decline of 5.1%.
- The fastest year-over-year change in Other Assets over five years came in Q3 2023 (growth of 771.3%), and the weakest in Q2 2022 (a decline of 89.1%).
- Business Quant data shows ALGS's Other Assets at $759,000 (Q2 2026), $759,000 (Q1 2026) and $715,000 (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 7.70 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 9.42 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 19.90 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | 700.00 Mn |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 14.60 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 4.90 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 10.02 Bn |
| 10 | Aligos Therapeutics | 21.97 Mn | -314.86 Mn | - | 268,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 268,000.00 |
| Jun 30, 2026 | 759,000.00 |
| Mar 31, 2026 | 759,000.00 |
| Dec 31, 2025 | 715,000.00 |
| Sep 30, 2025 | 713,000.00 |
| Jun 30, 2025 | 640,000.00 |
| Mar 31, 2025 | 632,000.00 |
| Dec 31, 2024 | 627,000.00 |
| Sep 30, 2024 | 635,000.00 |
| Jun 30, 2024 | 701,000.00 |
| Mar 31, 2024 | 841,000.00 |
| Dec 31, 2023 | 695,000.00 |
| Sep 30, 2023 | 697,000.00 |
| Jun 30, 2023 | 42,000.00 |
| Mar 31, 2023 | 397,000.00 |
| Dec 31, 2022 | 749,000.00 |
| Sep 30, 2022 | 80,000.00 |
| Jun 30, 2022 | 21,000.00 |
| Mar 31, 2022 | 1.56 Mn |
| Dec 31, 2021 | 1.03 Mn |
API Access
Aligos Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ALGS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();